Details for New Drug Application (NDA): 012342
✉ Email this page to a colleague
NDA 012342 describes PARNATE, which is a drug marketed by Concordia and is included in one NDA. It is available from two suppliers. Additional details are available on the PARNATE profile page.
The generic ingredient in PARNATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
The generic ingredient in PARNATE is tranylcypromine sulfate. There are six drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tranylcypromine sulfate profile page.
Summary for 012342
| Tradename: | PARNATE |
| Applicant: | Concordia |
| Ingredient: | tranylcypromine sulfate |
| Patents: | 0 |
Pharmacology for NDA: 012342
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 012342
Suppliers and Packaging for NDA: 012342
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PARNATE | tranylcypromine sulfate | TABLET;ORAL | 012342 | NDA AUTHORIZED GENERIC | Actavis Pharma, Inc. | 0591-5590 | 0591-5590-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0591-5590-01) |
| PARNATE | tranylcypromine sulfate | TABLET;ORAL | 012342 | NDA | Advanz Pharma (US) Corp. | 59212-447 | 59212-447-10 | 100 TABLET, FILM COATED in 1 BOTTLE (59212-447-10) |
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
| Approval Date: | Aug 16, 1985 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
